Improvement of Anxiety, Depression and fatigue after treatment of Anemia in patients with inflammatory bowel disease patients
Melhora da Ansiedade, Depressão e fadiga após tratamento de Anemia em pacientes com doença inflamatória intestinal
DOI:
https://doi.org/10.34119/bjhrv5n4-268Keywords:
inflammatory bowel disease, Anemia, ulcerative colitis, Crohn’s disease, quality of life, fatigue, Anxiety, DepressionAbstract
INTRODUCTION: Anemia is a common complication in inflammatory disease bowel (IBD). Many patients have this comorbidity ignored during clinical follow-up. Nonetheless, studies of anemic patients have a significant relationship between anemia and higher anxiety, depression and fatigue. This study evaluated the level of anxiety, depression and fatigue before and after treatment for anemia in mild anemic, IBD patients from the IBD Center of the UFJF University Hospital. OBJECTIVE: The objective of the present study was to investigate the improvement of anxiety, depression and fatigue after treatment of anemia in IBD patients. METHODS: In this cross-sectional study, 100 patients with CD (Crohn's disease) and 100 with RCUI (ulcerative colitis) were screened for anemia. For evaluation of anemia, complete blood count, ferritin, saturation index transferrin, serum levels of folic acid, serum iron and vitamin B12 was performed. In anemic patients, was evaluated and compared the levels of anxiety, depression and fatigue before and after anemia treatment. For the evaluation of anxiety was applied the hospital anxiety and depression scale (HADS), to assess fatigue was applied Chalder`s questionnaire. RESULTS: The evaluation average for anxiety before anemia treatment was 7.3 ± 4.3 and after treatment it was 5.3 ± 4.8 (p=0.0.08), the average of depression before treatment was 6.2 ± 5.2 and after treatment it was 4.9 ± 4.8 (p=0.08) and the average of fatigue before anemia treatment was 30.9 ± 8.7 and after treatment it was 21.6 ± 8.4 (p<0.001). Treatment with oral liposomal iron was effective in improving mild IDA and quality of life, as well as in decreasing fatigue in patients with inactive or mildly active IBD. CONCLUSION: The treatment of anemia in patients with IBD Brazilian outpatients showed statistically significant improvement in cases of anxiety and fatigue, although did not demonstrate a significant improvement in depression.
References
Testa A, Rispo A, Romano M, Riegler G, Selvaggi F, et al. (2016) The burden of anaemia in patients with inflammatory bowel diseases. Dig Liver Dis 48:267–270.
Filmann N, Rey J, Schneeweiss S, Ardizzone S, Bager P, et al. (2014) Prevalence of anemia in inflammatory bowel diseases in european countries: a systematic review and individual patient data meta-analysis. Inflamm Bowel Dis 20:936–945.
Bergamaschi G, Di Sabatino A, Albertini R, Ardizzone S, Biancheri, et al. (2010) Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment. Haematologica 95:199–205.
Zimmermann MB, Hurrell RF (2007) Nutritional iron deficiency. Lancet 370:511– 520.
Kulnigg S, Gasche C (2006) Systematic review: managing anaemia in Crohn’s disease. Aliment Pharmacol Ther 24:1507–1523.
Paula, W.D., Breguez, G.S., Machado, E.L., & Meireles, A.L. (2020). Prevalence of anxiety, depression, and suicidal ideation symptoms among university students: a systematic review.
Gasche C, Berstad A, Befrits R, Beglinger C, Dignass A, et al. (2007) Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 13:1545–1553.
Dignass AU, Gasche C, Bettenworth D, Birgegard G, Danese S, et al. (2015) European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis 9:211–222.
Kaitha S, Bashir M, Ali T (2015) Iron deficiency anemia in inflammatory bowel disease. World J Gastrointest Pathophysiol 6:62–72.
Lee TW, Kolber MR, Fedorak RN, van Zanten SV (2012) Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis. J Crohns Colitis 6:267–275.
de Silva AD, Tsironi E, Feakins RM, Rampton DS (2005) Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial. Aliment Pharmacol Ther 22:1097–1105.
Grisham MB (1994) Oxidants and free radicals in inflammatory bowel disease. Lancet 344:859–861
Lund EK, Wharf SG, Fairweather-Tait SJ, Johnson IT (1999) Oral ferrous sulfate supplements increase the free radical-generating capacity of feces from healthy volunteers. Am J Clin Nutr 69:250–255.
Erichsen K, Ulvik RJ, Grimstad T, Berstad A, Berge RK, Hausken T (2005) Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease. Aliment Pharmacol Ther 22:831–838.
Theurl I, Schroll A, Nairz M, Seifert M, Theurl M, et al. (2011) Pathways for the regulation of hepcidin expression in anemia of chronic disease and iron deficiency anemia in vivo. Haematologica 96:1761–1769.
Befrits R, Wikman O, Blomquist l, Hjortswang H, Hammarlund P, et al. (2013) Anemia and iron deficiency in inflammatory bowel disease: an open, prospective, observational study on diagnosis, treatment with ferric carboxymaltose and quality of life. Scand J Gastroenterol 48:1027-32.
Bonovas S, Fiorino G, Allocca M, Lytras T, Tsantes A, Peyrin-Biroulet L et al. (2016) Intravenous versus oral iron for the treatment of anemia in inflammatory bowel disease: a systematic review and meta-analysis of randomized controlled trials. Medicine 95:e2308.
Simao AMS, Bolean M, Cury TAC, Stabeli RG, Itri R, Ciancaglini P (2015) Liposomal systems as carriers for bioactive compounds. Biophys Rev 7:391–397.
Brilli E, Romano A, Fabiano A, Zambito Y, Di Raimondo F, Tarantino G (2016) Sucrosomial technology is able to promote ferric iron absorption: pre-clinical and clinical evidences. Blood 128:3618.
Pisani A, Riccio E, Sabbatini M, Andreucci M, Del Rio A, Visciano B (2015) Effect of oral liposomal iron versus intravenous iron for treatment of iron deficiency anaemia in CKD patients: a randomized trial. Nephrol Dial Transplant 30:645–652.
Podolsky DK (2016) Inflammatory bowel disease- review article N Engl J Med 347:417-429.
World Health Organization Iron Deficiency Anemia Assessment (2011) Prevention And Control A Guide For Programme Managers. Report N:Who/NHD/01.3
Dignass A, Farrag K, Stein J (2018) Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions. Int J Chronic Dis 18: 9394060 https://doi.org/10.1155/2018/9394060
Satsangi J, Silverberg MS, Vermeire S, Colombel JF The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55:749–753.
Vermeire S, Schreiber S, Sandborn WJ , Dubois C, Rutgeerts P (2010) Correlation between the Crohn’s Disease Activity and Harvey-Bradshaw Indices in Assessing Crohn’s Disease Severity Clin Gastroenterol Hepatol 8:357-63.
Best WR, Becktel JM, Singleton JW, Kern F Jr (1976) Development of a Crohn’s disease activity index National Cooperative Crohn’s Disease Study Gastroenterology 70:439-444.
Truelove SC and Witts LJ (1955) Cortisone in ulcerative colitis. Br Med J 2(4947): 1041-1048.
Pontes RM, Miszputen SJ, Ferreira-Filho OF, Miranda C , Ferraz MB (2004) Quality of life in patients with inflammatory bowel diseases: translation to portuguese language and validation of the "inflammatory bowel disease questionnaire" (IBDQ) Arq gastroenterol 41:137-43.
Cho HJ, Costa E, Menezes PR, Chalder T, Bhugra D, Wessely S (2007) Cross-cultural validation of the chalder fatigue questionnaire in brazilian primary care. J Psychosom Res 62: 301-304.
Osterberg L, and Blaschke T (2005) Adherence to Medication. N Engl J Med 353:487- 497.
Antunes CV, Hallack Neto AE, Nascimento CR, Chebli LA, Moutinho IL, Pinheiro Bdo V et al (2015) Anemia in inflammatory bowel disease outpatients: prevalence, risk factors, and etiology. Biomed Res Int 2015:728925. http://dx.doi.org/10.1155/2015/728925
Bager P, Befrits R, Wilman O, Lindgren S, Moum B, Hjortswang H et al. (2011) The prevalence of anemia and iron deficiency in IBD outpatients. Scand J Gastroenterol 26: 304-09.
Schmidt C, Ahmad T, Tulassay Z, BAumgart DC, Bokemever B, Howaldt S et al. (2016) Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study. Aliment Pharmacol Ther 44:259–270.
Indriolo A, Signorelli S, Greco S, Ravelli P (2014) Comparison between liposomal iron and ferrous sulfate in patients with iron deficiency anemia and inflammatory bowel disease. A pilot controlled study. Dig Liver Dis 46 (2):S65.
Steinbicker AU (2014) A Novel Treatment Of Anemia In Inflammation. Blood 124: 2618-19.
Baird-Gunning J, Bromley J (2016) Correcting iron deficiency Aust Prescr 39: 193-
Erichsen K, Ulvik RJ, Grimstad T, Berstad A, Berge RK, Hausken T (2005) Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease Aliment Pharmacol Ther 22:831–838.
Yuan L, Geng L, Ge L, Yu P, Duan X, Chen J, Chang Y (2013) Effect of iron liposomes on anemia of inflammation. Int J Pharm 454:82-89.
Eliadou E, Kini G, Huang J, Champion A, Inns SJ (2017) Intravenous Iron Replacement Improves Quality of Life in Hypoferritinemic Inflammatory Bowel Disease Patients with and without Anemia. Dig Dis 35:444-448.
González Alayón C, Pedrajas Crespo C, Marín Pedrosa S, Benítez JM, Iglesias Flores E, Salgueiro Rodríguez I et al. (2018) Prevalence of iron deficiency without anaemia in inflammatory bowel disease and impact on health-related quality of life. Gastroenterol Hepatol 41:22-29.
Nienke Z, Borren NZ, Van der Woude CJ, Ananthakrishnan AN (2019) Fatigue in IBD: epidemiology, pathophysiology and management. Nat Rev Gastroenterol Hepatol 16:247-259.
Huppertz-Hauss G, Høivik ML, Jelsness-Jørgensen LP, Opheim R, Henriksen M, Høie O et al (2017) Fatigue in a population-based cohort of patients with inflammatory bowel disease 20 years after diagnosis: The IBSEN study. Scand J Gastroenterol 52:351-358. https://www.tandfonline.com/doi/full/10.1080/00365521.2016.1256425
